Loading…
Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling
Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hyd...
Saved in:
Published in: | Chemical biology & drug design 2011-10, Vol.78 (4), p.651-658 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3 |
container_end_page | 658 |
container_issue | 4 |
container_start_page | 651 |
container_title | Chemical biology & drug design |
container_volume | 78 |
creator | Huang, Xiao Y. Shan, Zhi J. Zhai, Hong L. Su, Li Zhang, Xiao Y. |
description | Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design.
Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking. |
doi_str_mv | 10.1111/j.1747-0285.2011.01195.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_889176206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1221136263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</originalsourceid><addsrcrecordid>eNqNkEtv1DAUha0K1Bf9C8g72CT4EdvxBmnI9EFbygJQl5YnuaYeMklrJ-3Mv8dh2llWWLJ8pHPuse6HEKYkp-l8WuZUFSojrBQ5I5Tm6WqRr_fQ4c54s9NKHaCjGJeEFIVg5T46YFRpSog-RDc_hrHZ4L7Dwx3gWTf42nY1BDyrB__oh2Q5XPXjygbf4TkE_2iTAREvNvhb30I9tjYk1UDru9_v0Ftn2wgnz-8x-nV2-rO6yK6_n3-tZtdZLYQUGSO6YJICaWDBRWEBCuaItY1mtpEL4oQjpbVc8rSW41Jw4NJp7ZjSjQPHj9GHbe996B9GiINZ-VhD29oO-jGastRUSUZkSn58NUkZo5RLJnmKlttoHfoYAzhzH3xafGMoMRN3szQTUjPhNRN384-7WafR98-_jIsVNLvBF9Ap8HkbePItbP672FRf5vNJpoJsW-DjAOtdgQ1_jFRcCXN7c25KdTVX4rIyl_wvu4GfnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1221136263</pqid></control><display><type>article</type><title>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Huang, Xiao Y. ; Shan, Zhi J. ; Zhai, Hong L. ; Su, Li ; Zhang, Xiao Y.</creator><creatorcontrib>Huang, Xiao Y. ; Shan, Zhi J. ; Zhai, Hong L. ; Su, Li ; Zhang, Xiao Y.</creatorcontrib><description>Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design.
Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.</description><identifier>ISSN: 1747-0277</identifier><identifier>EISSN: 1747-0285</identifier><identifier>DOI: 10.1111/j.1747-0285.2011.01195.x</identifier><identifier>PMID: 21791009</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>anticancer activity ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antitumor activity ; Casein Kinase II - antagonists & inhibitors ; Casein Kinase II - metabolism ; CoMFA ; CoMSIA ; Coumarin ; Coumarins - chemistry ; Coumarins - pharmacology ; docking ; Drug Design ; Drug development ; Electrostatic properties ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Humans ; Hydrogen ; Hydrogen bonding ; Hydrophobicity ; Models, Molecular ; Molecular modelling ; Neoplasms - drug therapy ; Oxygen ; Protein Binding ; Protein kinase ; protein kinase 2 ; Quantitative Structure-Activity Relationship ; Statistical analysis ; Statistics</subject><ispartof>Chemical biology & drug design, 2011-10, Vol.78 (4), p.651-658</ispartof><rights>2011 John Wiley & Sons A/S</rights><rights>2011 John Wiley & Sons A/S.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</citedby><cites>FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21791009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Xiao Y.</creatorcontrib><creatorcontrib>Shan, Zhi J.</creatorcontrib><creatorcontrib>Zhai, Hong L.</creatorcontrib><creatorcontrib>Su, Li</creatorcontrib><creatorcontrib>Zhang, Xiao Y.</creatorcontrib><title>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</title><title>Chemical biology & drug design</title><addtitle>Chem Biol Drug Des</addtitle><description>Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design.
Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.</description><subject>anticancer activity</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antitumor activity</subject><subject>Casein Kinase II - antagonists & inhibitors</subject><subject>Casein Kinase II - metabolism</subject><subject>CoMFA</subject><subject>CoMSIA</subject><subject>Coumarin</subject><subject>Coumarins - chemistry</subject><subject>Coumarins - pharmacology</subject><subject>docking</subject><subject>Drug Design</subject><subject>Drug development</subject><subject>Electrostatic properties</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Hydrogen</subject><subject>Hydrogen bonding</subject><subject>Hydrophobicity</subject><subject>Models, Molecular</subject><subject>Molecular modelling</subject><subject>Neoplasms - drug therapy</subject><subject>Oxygen</subject><subject>Protein Binding</subject><subject>Protein kinase</subject><subject>protein kinase 2</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Statistical analysis</subject><subject>Statistics</subject><issn>1747-0277</issn><issn>1747-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkEtv1DAUha0K1Bf9C8g72CT4EdvxBmnI9EFbygJQl5YnuaYeMklrJ-3Mv8dh2llWWLJ8pHPuse6HEKYkp-l8WuZUFSojrBQ5I5Tm6WqRr_fQ4c54s9NKHaCjGJeEFIVg5T46YFRpSog-RDc_hrHZ4L7Dwx3gWTf42nY1BDyrB__oh2Q5XPXjygbf4TkE_2iTAREvNvhb30I9tjYk1UDru9_v0Ftn2wgnz-8x-nV2-rO6yK6_n3-tZtdZLYQUGSO6YJICaWDBRWEBCuaItY1mtpEL4oQjpbVc8rSW41Jw4NJp7ZjSjQPHj9GHbe996B9GiINZ-VhD29oO-jGastRUSUZkSn58NUkZo5RLJnmKlttoHfoYAzhzH3xafGMoMRN3szQTUjPhNRN384-7WafR98-_jIsVNLvBF9Ap8HkbePItbP672FRf5vNJpoJsW-DjAOtdgQ1_jFRcCXN7c25KdTVX4rIyl_wvu4GfnA</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Huang, Xiao Y.</creator><creator>Shan, Zhi J.</creator><creator>Zhai, Hong L.</creator><creator>Su, Li</creator><creator>Zhang, Xiao Y.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201110</creationdate><title>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</title><author>Huang, Xiao Y. ; Shan, Zhi J. ; Zhai, Hong L. ; Su, Li ; Zhang, Xiao Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>anticancer activity</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antitumor activity</topic><topic>Casein Kinase II - antagonists & inhibitors</topic><topic>Casein Kinase II - metabolism</topic><topic>CoMFA</topic><topic>CoMSIA</topic><topic>Coumarin</topic><topic>Coumarins - chemistry</topic><topic>Coumarins - pharmacology</topic><topic>docking</topic><topic>Drug Design</topic><topic>Drug development</topic><topic>Electrostatic properties</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Hydrogen</topic><topic>Hydrogen bonding</topic><topic>Hydrophobicity</topic><topic>Models, Molecular</topic><topic>Molecular modelling</topic><topic>Neoplasms - drug therapy</topic><topic>Oxygen</topic><topic>Protein Binding</topic><topic>Protein kinase</topic><topic>protein kinase 2</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Statistical analysis</topic><topic>Statistics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Xiao Y.</creatorcontrib><creatorcontrib>Shan, Zhi J.</creatorcontrib><creatorcontrib>Zhai, Hong L.</creatorcontrib><creatorcontrib>Su, Li</creatorcontrib><creatorcontrib>Zhang, Xiao Y.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical biology & drug design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Xiao Y.</au><au>Shan, Zhi J.</au><au>Zhai, Hong L.</au><au>Su, Li</au><au>Zhang, Xiao Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</atitle><jtitle>Chemical biology & drug design</jtitle><addtitle>Chem Biol Drug Des</addtitle><date>2011-10</date><risdate>2011</risdate><volume>78</volume><issue>4</issue><spage>651</spage><epage>658</epage><pages>651-658</pages><issn>1747-0277</issn><eissn>1747-0285</eissn><abstract>Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design.
Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21791009</pmid><doi>10.1111/j.1747-0285.2011.01195.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1747-0277 |
ispartof | Chemical biology & drug design, 2011-10, Vol.78 (4), p.651-658 |
issn | 1747-0277 1747-0285 |
language | eng |
recordid | cdi_proquest_miscellaneous_889176206 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | anticancer activity Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antitumor activity Casein Kinase II - antagonists & inhibitors Casein Kinase II - metabolism CoMFA CoMSIA Coumarin Coumarins - chemistry Coumarins - pharmacology docking Drug Design Drug development Electrostatic properties Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Humans Hydrogen Hydrogen bonding Hydrophobicity Models, Molecular Molecular modelling Neoplasms - drug therapy Oxygen Protein Binding Protein kinase protein kinase 2 Quantitative Structure-Activity Relationship Statistical analysis Statistics |
title | Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-04T09%3A40%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20on%20the%20Anticancer%20Activity%20of%20Coumarin%20Derivatives%20by%20Molecular%20Modeling&rft.jtitle=Chemical%20biology%20&%20drug%20design&rft.au=Huang,%20Xiao%20Y.&rft.date=2011-10&rft.volume=78&rft.issue=4&rft.spage=651&rft.epage=658&rft.pages=651-658&rft.issn=1747-0277&rft.eissn=1747-0285&rft_id=info:doi/10.1111/j.1747-0285.2011.01195.x&rft_dat=%3Cproquest_cross%3E1221136263%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1221136263&rft_id=info:pmid/21791009&rfr_iscdi=true |